Skip to main content

Table 2 Most frequently occurring adverse events (AE) in the safety population (incidence ≥ 3.0%)

From: Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease

Preferred term Percent of patients
  N = 902
Patients with at least 1 AE 74.7
Weight decreased 11.2
Fall 8.8
Agitation 6.8
Urinary tract infection 5.9
Aggression 5.8
Diarrhea 4.3
Nausea 3.5
Hypertension 3.1
Syncope 3.1
Depression 3.0
Weight increased 3.0